C136H136F6N44O13 — CID 162098984
8-[6-(4-tert-butylpyrazol-1-yl)-3-pyridinyl]-1-cyclopropyl-3-propyl-7H-purine-2,6-dione;1-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-5-methyl-N-pyridin-3-ylpyrazole-3-carboxamide;1-cyclopropyl-8-[6-(4-ethylpyrazol-1-yl)-3-pyridinyl]-3-propyl-7H-purine-2,6-dione;1-cyclopropyl-8-[6-(4-methylpyrazol-1-yl)-3-pyridinyl]-3-propyl-7H-purine-2,6-dione;1-cyclopropyl-3-propyl-8-[6-[4-[4-(trifluoromethyl)phenyl]pyrazol-1-yl]-3-pyridinyl]-7H-purine-2,6-dione;1-cyclopropyl-3-propyl-8-[6-[4-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-7H-purine-2,6-dione (PubChem CID 162098984) has the molecular formula C136H136F6N44O13 and a molecular weight of 2708.87 g/mol. Its IUPAC name is 8-[6-(4-tert-butylpyrazol-1-yl)-3-pyridinyl]-1-cyclopropyl-3-propyl-7H-purine-2,6-dione;1-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-5-methyl-N-pyridin-3-ylpyrazole-3-carboxamide;1-cyclopropyl-8-[6-(4-ethylpyrazol-1-yl)-3-pyridinyl]-3-propyl-7H-purine-2,6-dione;1-cyclopropyl-8-[6-(4-methylpyrazol-1-yl)-3-pyridinyl]-3-propyl-7H-purine-2,6-dione;1-cyclopropyl-3-propyl-8-[6-[4-[4-(trifluoromethyl)phenyl]pyrazol-1-yl]-3-pyridinyl]-7H-purine-2,6-dione;1-cyclopropyl-3-propyl-8-[6-[4-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-7H-purine-2,6-dione.
| Compound Name | 8-[6-(4-tert-butylpyrazol-1-yl)-3-pyridinyl]-1-cyclopropyl-3-propyl-7H-purine-2,6-dione;1-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-5-methyl-N-pyridin-3-ylpyrazole-3-carboxamide;1-cyclopropyl-8-[6-(4-ethylpyrazol-1-yl)-3-pyridinyl]-3-propyl-7H-purine-2,6-dione;1-cyclopropyl-8-[6-(4-methylpyrazol-1-yl)-3-pyridinyl]-3-propyl-7H-purine-2,6-dione;1-cyclopropyl-3-propyl-8-[6-[4-[4-(trifluoromethyl)phenyl]pyrazol-1-yl]-3-pyridinyl]-7H-purine-2,6-dione;1-cyclopropyl-3-propyl-8-[6-[4-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-7H-purine-2,6-dione |
|---|---|
| PubChem CID | 162098984 |
| Molecular Formula | C136H136F6N44O13 |
| Molecular Weight | 2708.87 g/mol |
| Exact Mass | 2707.12 |
| IUPAC Name | 8-[6-(4-tert-butylpyrazol-1-yl)-3-pyridinyl]-1-cyclopropyl-3-propyl-7H-purine-2,6-dione;1-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-5-methyl-N-pyridin-3-ylpyrazole-3-carboxamide;1-cyclopropyl-8-[6-(4-ethylpyrazol-1-yl)-3-pyridinyl]-3-propyl-7H-purine-2,6-dione;1-cyclopropyl-8-[6-(4-methylpyrazol-1-yl)-3-pyridinyl]-3-propyl-7H-purine-2,6-dione;1-cyclopropyl-3-propyl-8-[6-[4-[4-(trifluoromethyl)phenyl]pyrazol-1-yl]-3-pyridinyl]-7H-purine-2,6-dione;1-cyclopropyl-3-propyl-8-[6-[4-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-7H-purine-2,6-dione |
| SMILES | CCCn1c(=O)n(C2CC2)c(=O)c2[nH]c(-c3ccc(-n4cc(-c5ccc(C(F)(F)F)cc5)cn4)nc3)nc21.CCCn1c(=O)n(C2CC2)c(=O)c2[nH]c(-c3ccc(-n4cc(C(C)(C)C)cn4)nc3)nc21.CCCn1c(=O)n(C2CC2)c(=O)c2[nH]c(-c3ccc(-n4cc(C(F)(F)F)cn4)nc3)nc21.CCCn1c(=O)n(C2CC2)c(=O)c2[nH]c(-c3ccc(-n4cc(C)cn4)nc3)nc21.CCCn1c(=O)n(C2CC2)c(=O)c2[nH]c(-c3ccc(-n4cc(CC)cn4)nc3)nc21.CCCn1c(=O)n(C2CC2)c(=O)c2[nH]c(-c3ccc(-n4nc(C(=O)Nc5cccnc5)cc4C)nc3)nc21 |
| InChI | InChI=1S/C26H22F3N7O2.C26H25N9O3.C23H27N7O2.C21H23N7O2.C20H18F3N7O2.C20H21N7O2/c1-2-11-34-23-21(24(37)36(25(34)38)19-8-9-19)32-22(33-23)16-5-10-20(30-12-16)35-14-17(13-31-35)15-3-6-18(7-4-15)26(27,28)29;1-3-11-33-23-21(25(37)34(26(33)38)18-7-8-18)30-22(31-23)16-6-9-20(28-13-16)35-15(2)12-19(32-35)24(36)29-17-5-4-10-27-14-17;1-5-10-28-20-18(21(31)30(22(28)32)16-7-8-16)26-19(27-20)14-6-9-17(24-11-14)29-13-15(12-25-29)23(2,3)4;1-3-9-26-19-17(20(29)28(21(26)30)15-6-7-15)24-18(25-19)14-5-8-16(22-11-14)27-12-13(4-2)10-23-27;1-2-7-28-17-15(18(31)30(19(28)32)13-4-5-13)26-16(27-17)11-3-6-14(24-8-11)29-10-12(9-25-29)20(21,22)23;1-3-8-25-18-16(19(28)27(20(25)29)14-5-6-14)23-17(24-18)13-4-7-15(21-10-13)26-11-12(2)9-22-26/h3-7,10,12-14,19H,2,8-9,11H2,1H3,(H,32,33);4-6,9-10,12-14,18H,3,7-8,11H2,1-2H3,(H,29,36)(H,30,31);6,9,11-13,16H,5,7-8,10H2,1-4H3,(H,26,27);5,8,10-12,15H,3-4,6-7,9H2,1-2H3,(H,24,25);3,6,8-10,13H,2,4-5,7H2,1H3,(H,26,27);4,7,9-11,14H,3,5-6,8H2,1-2H3,(H,23,24) |
| InChIKey | ZEPXTTJOFJQEEM-UHFFFAOYSA-N |
| XLogP | 18.10 |
| TPSA | 662.33 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 50 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 199 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2708.87 |
| LogP ≤ 5 | 18.10 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 50 |